✦ LIBER ✦

Phase IB study of low-dose intraperitoneal recombinant Interleukin-2 in patients with refractory advanced ovarian cancer: Rationale and preliminary report

✍ Scribed by Uziel Beller; Abraham Chachoua; James L. Speyer; Joan Sorich; Margaret Dugan; Leonard Liebes; Roberta Hayes; E.Mark Beckman

Book ID: 119053163
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 602 KB
Volume: 34
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(89)90182-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase IB study of low-dose intraperitone

Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: Rationale and preliminary report

✍ U Beller; A Chachoua; JL Speyer; J Sorich; M Dugan; L Liebes; R Hayes; EM Beckma 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Phase IB study on prevention of surgery-

Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients

✍ Katia Cerea; Fabrizio Romano; Andrea Ferrari Bravo; Vittorio Motta; Fabio Uggeri 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Phase 2 Study of TLK286 (GST P1-1 Activa

Phase 2 Study of TLK286 (GST P1-1 Activated Glutathione Analog) in patients with platinum and paclitaxel refractory/resistant advanced epithelial ovarian cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Toxicity report of a phase 1/2 dose-esca

Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy

✍ Samuel Bral; Michaël Duchateau; Harijati Versmessen; Douwe Verdries; Benedikt En 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

Preliminary results of a dose-intense ph

Preliminary results of a dose-intense phase II study of a combination chemotherapy regimen with cisplatin (CDDP) and epirubicin (EPI) including medroxyprogesterone acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancer

✍ G. Mantovani; A. Macciò; P. Lai; E. Massa; M.C. Mudu; G. Manca; C. Mulas; D. Mas 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 163 KB